Other Affiliated Sites
开元体育(中国)官方网站
开元体育·(中国)官方APP下载
开元体育平台(中国)官方网站app下载
开元体育官网(中国)官方下载-IOS/安卓通用版/手机APP下载
开云app(中国)官方网站-ios/安卓版/手机版app下载
开云·APP官方入口(中国)官方网站-IOS/安卓通用版/手机app
开云·APP(kaiyun)(中国)官方网站-IOS/Android通用版/手机app下载
华体会·(HTH)官网APP下载 - Apple app store
江南体育·(中国)官方网站 - ios/安卓版/手机APP下载
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2020.10.26
PASSING OF CONSISTENCY EVALUATION FOR THE GENERIC DRUG OF ALL STRENGTHS OF "ENOX...
2020.10.16
DATE OF BOARD MEETING
2020.10.06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2020.09.24
Notification Letter and Request Form to Non-Registered Shareholder
2020.09.24
2020 Interim Report
2020.09.21
"ENOXAPARIN SODIUM INJECTION" OBTAINS APPROVAL FROM FDA
2020.09.21
"ENOXAPARIN SODIUM INJECTION" OBTAINS APPROVAL FROM FDA
2020.09.19
CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE AND WAIVER FROM ...
2020.09.11
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2020.09.02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
第一页
上一页
10
11
12
13
14
下一页
最后一页
